Avilex Pharma is a spin out from the University of Copenhagen, founded by Professor Kristian Strømgaard and Ass. Prof. Anders Bach of the Department of Drug Design and Pharmacology.
Read MoreAvilex Pharma announces first human dosing of AVLX-144 – a game-changing treatment for acute ischemic stroke.
Read More